Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

A -- Advances in Biotechnology and the Biosciences for Warfighter Performance and Protection

Active
BAA-05-02-HEFederal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract titled "A -- Advances in Biotechnology and the Biosciences for Warfighter Performance and Protection" was a presolicitation issued by the Department of Defense under the Air Force Research Laboratory, located at Wright Patterson AFB, Ohio. It aimed to explore advancements in biotechnology and biosciences with the goal of enhancing warfighter performance and protection. Although no specific NAICS code or set-aside type was indicated, the contract sought innovative research proposals in this field. The point of contact for this contract was Contracting Officer Timothy H Hannah, reachable via email and phone at the Wright Patterson AFB office. This opportunity was posted on October 1, 2009, but has since been replaced by another solicitation, BAA-09-02-RH. The contract focused on promoting cutting-edge scientific research to improve capabilities critical to national defense and warfighter safety.

General Info

Department of Defense seeks biotech research to enhance warfighter performance and protection.

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)

Place of Performance

OH

Set-Aside

NONE

Documents

8

BAA 05-02 HE - Advances in Biotechnology and the Biosciences

DOC, High priority: read this firstrfp
High

BAA 05-02 HE: Advances in Biotechnology and the Biosciences for Warfighter Performance and Protection

DOC, High priority: read this firstrfp
High

BAA 05-02-HE Amendment 01

DOC, High priority: read this firstamendment
High

BAA 05-02-HE Amendment 03

DOC, High priority: read this firstamendment
High

BAA 05-02 HE Amendment 03 - Advances in Biotechnology and the Biosciences

DOC, High priority: read this firstamendment
High

BAA 05-02-HE Amendment 04

DOC, High priority: read this firstamendment
High

BAA 05-02-HE, Amendment 05

DOC, High priority: read this firstamendment
High

BAA 05-02 HE Amendment 05 - Advances in Biotechnology and the Biosciences

DOC, High priority: read this firstamendment
High

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

9 updates
PhasePresolicitation
Posted

Presolicitation

Notice updated

The notice description changed.

Notice updated

Notice details unchanged. Attachments may have changed.

Notice updated

The notice description changed. The point of contact changed.

Notice updated

The notice description changed.

Notice updated

The notice description changed. The point of contact changed.

Notice updated

The notice description changed.

Notice updated

Notice details unchanged. Attachments may have changed.

Notice updated

Notice details unchanged. Attachments may have changed.

Notice updated

The notice description changed.

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → FA8650 USAF Afmc Afrl Pzl Afrl/pzl
Contacts1 person available
OfficeWRIGHT PATTERSON AFB, OH, 45433-7541, USA
Office AddressWRIGHT PATTERSON AFB, OH, 45433-7541, USA
Contacts
Timothy H HannahContracting Officer

Full Description

Show more
Replaced by BAA-09-02-RH

Similar Contracts

Same NAICS industry code

NAICS: 541714
New
Grant
Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)
Solicitation # RFA-AI-28-012
The National Institute of Allergy and Infectious Diseases (NIAID) has issued solicitation RFA-AI-28-012 to establish a consortium of Translational Centers Using Microphysiological Systems for Infectious Diseases (TCMID). The primary objective is to refine and validate human tissue models using Microphysiological Systems (MPS) to a level consistent with regulatory qualifications, thereby promoting their adoption by product developers and reducing reliance on laboratory animals. This initiative aligns with NIH and FDA guidance on New Approach Methodologies (NAMs) to accelerate the development of safer medical interventions by capturing human variability and patient-specific characteristics. The program is structured around an Administrative Core, a Qualification Core, and Scientific Cores, with a heavy emphasis on technical readiness, reproducibility, and regulatory acceptance. Key deliverables include the validation of assays for specific endpoints and the submission of regulatory packages. Applicants must be domestic entities, as foreign organizations and foreign subawards are strictly prohibited. Required personnel must possess deep expertise in infectious diseases, MPS platforms, bioinformatics, and FDA submission processes. Applications are due by January 29, 2027, and must be submitted via the NIH ASSIST system or approved institutional system-to-system solutions. Evaluation is based on an overall impact score considering the project's significance, the suitability of the investigators, and the quality of the institutional environment. Mandatory application components include a Data Management and Sharing Plan and a Benchmarks and Timeline PDF not exceeding six pages. Awardees must also adhere to strict cybersecurity incident reporting guidelines, notifying HHS within 48 hours of any discovery.
National Institutes Of Health

POSTED

about 21 hours ago

DEADLINE

in 3 months
View Details
NAICS: 541714
New
Grant
Immune Tolerance Network (UM1 Clinical Trial Required)
Solicitation # RFA-AI-28-005
The National Institutes of Health, under the Department of Health and Human Services, is seeking applications through solicitation RFA-AI-28-005 to continue the Immune Tolerance Network (ITN). This cooperative agreement aims to develop tolerogenic therapies for immune-mediated disorders, specifically focusing on autoimmune diseases, allergic diseases and asthma, and the immune-mediated consequences of transplantation. The network operates through four integrated functional areas: Leadership, Clinical Operations, Core Laboratory, and Bioinformatics. Its primary objectives include designing and conducting clinical trials, performing integrated mechanistic studies, and sharing research results. Eligible applicants include small businesses and other for-profit organizations, though non-domestic entities are ineligible. Applications are evaluated based on scientific and technical merit, with a primary focus on significance and the likelihood of exerting a sustained influence on the research field. Key requirements include maintaining active registrations in SAM.gov, eRA Commons, and Grants.gov, as well as adhering to strict cybersecurity incident reporting and human subject protection protocols. The project requires a minimum effort of 3.6 person months per year for the PD/PI and mandates participation in a kick-off meeting in Bethesda, Maryland, and bi-annual steering meetings. Applications must follow specific page limits for the research strategy subsections and include detailed plans for clinical trial implementation, data management, and biorepository services.
National Institutes Of Health

POSTED

about 21 hours ago

DEADLINE

in 3 months
View Details
NAICS: 541714
New
Federal
Pre-Award Synopsis Texas Shield
Solicitation # DARPA-SN-27-07
The Defense Advanced Research Projects Agency (DARPA), through its Biological Technologies Office (BTO), intends to enter into an agreement with The University of Texas System consortium of universities for the Texas Shield Program. This integrated research initiative, identified by solicitation number DARPA-SN-27-07 and NAICS code 541714, focuses on developing autonomous and semi-autonomous medical technologies and scalable solutions for critical medical consumables. The primary goal is to support lifesaving medical care in contested, austere, and resource-limited environments. Key technical areas of focus include autonomous medical and robotic surgical systems, casualty evacuation, artificial-blood and supply innovation, AI-enabled clinical decision support, and mass-casualty science and simulation. This notice is a pre-award synopsis and is not a request for proposals or a competitive solicitation. Interested entities are invited to submit information by November 15, 2026, to TexasShieldxBTO@darpa.mil detailing their technical expertise, integrated research infrastructure, clinical-validation capabilities, and multi-institutional coordination capacity. Additionally, respondents must describe their consortium organizational structure, commercialization capabilities, facility clearance levels, and their ability to handle Controlled Unclassified Information. The government will not reimburse any costs associated with the preparation or submission of information in response to this notice.
Defense Advanced Research Projects Agcy

POSTED

5 days ago

DEADLINE

in 25 days
View Details
NAICS: 541714
New
Federal
Q--AMPLICON SEQUENCING SERVICES
Solicitation # 140G0226Q0047
Solicitation 140G0226Q0047 is a firm-fixed-price request for a Blanket Purchase Agreement (BPA) to provide next generation amplicon sequencing services for the USGS Upper Midwest Water Science Center’s Michigan Bacteriological Research Laboratory. The scope of work includes providing all equipment, labor, travel, and materials necessary to support research on bacterial pathogens, harmful algal blooms, microbial ecology, antibiotic resistance, and microbial source tracking. Key technical requirements include the use of Illumina MiSeq or AVITI sequencing technologies and the potential for library preparation for 16S V4 amplicon sequencing. The BPA has a total not-to-exceed value of 250,000 dollars with an estimated period of performance from September 17, 2026, to September 16, 2031. The award process prioritizes non-priced factors significantly over cost, focusing on the offeror's qualifications and technical performance. Evaluation criteria include a detailed listing of on-site equipment and calibration dates, personnel experience, internal quality assurance procedures, and a technical narrative not exceeding two pages. Performance will be executed in Lansing, Michigan, with delivery terms set as FOB Destination. Administrative requirements include electronic invoicing via the Internet Payment Platform and compliance with various federal regulations, including the Buy American Act and specific security prohibitions regarding telecommunications equipment. Proposals must be submitted to the USGS OAG Denver Acquisition Branch by September 11, 2026.
Ofc Of Acquisition Grants-Denver

POSTED

5 days ago

DEADLINE

in 3 days
View Details

More opportunities from Department Of Defense → FA8650 USAF Afmc Afrl Pzl Afrl/pzl

Same awarding agency

NAICS: 541715
Federal
AFRL Enterprise CSO: Centralized Open Spiral
Solicitation # FA865226SC005
Solicitation FA865226SC005 is a Centralized, Open Two-Step Spiral issued by the Air Force Research Laboratory under the Defense Commercial Solutions Opening (CSO) framework in accordance with R-DFARS 212.70. The government is seeking Commercial Solutions Brief (CSB) submissions for innovative solutions ranging from advanced component development to operational systems development, specifically limited to Foundational Technologies (AFRL/RE). This procurement follows a two-step process where only CSB submissions are currently requested; offerors must be categorized as Selectable during the Step One evaluation to be invited to Step Two, which involves the submission of a Commercial Solutions Proposal (CSP). The deadline for Step One CSB submissions is 5:00 PM Eastern on April 30, 2027. Submissions must align with the Areas of Interest identified in Attachment 1 of the AFRL Enterprise CSO and follow the formatting instructions in Section 7 and Attachment 2 of the main announcement. While there is no limit on the number of CSBs a single offeror may submit, each must present a unique approach. Submissions should be emailed to afrl.cso.mailbox@us.af.mil, though those containing Controlled Unclassified Information must be transmitted via the DoD SAFE system. This spiral was noted as cancelled effective June 4, 2026, with future spirals transitioning to a decentralized model issued by respective Mission Organizations.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

5 months ago

DEADLINE

in 6 months
View Details
NAICS: 541715
Federal
Endless Forge
Solicitation # FA2394-26-R-B003
Endless Forge is a Manufacturing as a Service initiative led by the Air Force Research Laboratory Materials and Manufacturing Directorate to establish an adaptive, scalable, and resilient production network for the US industrial base. The program aims to shift from sequential value chains to regionalized production networks, enabling the Department of the Air Force to rapidly scale weapon systems based on battlefield performance. With a total estimated program cost of 149 million dollars and multiple awards anticipated, the solicitation focuses on two primary Areas of Interest: technology sprints to reduce risk in enabling technologies like digital certification and software-defined manufacturing, and a technology demonstration to validate the concept across domains such as space systems and autonomous platforms. This unrestricted solicitation, number FA2394-26-R-B003, utilizes a two-step process requiring a five-page white paper followed by a full proposal for selected offerors, with a response deadline of February 19, 2028. Anticipated contracts include Other Transaction for Prototype and Cost Plus Fixed Fee types, with a technical performance period of 33 months. Key requirements include strict adherence to security risk reviews for key personnel to mitigate foreign influence, compliance with NIST SP 800-171 and CMMC cybersecurity standards, and the use of the Wide Area Workflow system for invoicing. Deliverables encompass research and development data, scientific and technical reports, and hardware prototypes that must meet MIL-STD-130 unique item identification and MIL-STD-129 packaging standards.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

5 months ago

DEADLINE

in over 1 year
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS